Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Samarium 153 and Double Autologous Bone Marrow Transplant in Stage IV Breast Cancer
NCT00003086Phase 2Terminated
- Sponsor
- LSU Health Shreveport
- Start
- Mar 1997
- Primary completion
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of samarium-153 lexidronam in breast cancer, sponsored by LSU Health Shreveport. Started Mar 1997; status: terminated.
02
Drugs
samarium-153 lexidronam
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003086.